Adult Acinetobacter meningitis and its comparison with non-Acinetobacter gram-negative bacterial meningitis

Shu-Fang Chen1, Wen-Neng Chang, Cheng-Hsien Lu

  • 1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung, Kaohsiung, Taiwan.

Insights

Acinetobacter meningitis, particularly post-neurosurgical cases, shows high antibiotic resistance. Meropenem is a potential initial treatment for this challenging Gram-negative bacterial meningitis.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Microbiology

Background:

  • Gram-negative bacterial meningitis (GNBM) is a serious infection.
  • Acinetobacter species are increasingly recognized pathogens, especially in hospital-acquired infections.
  • Post-neurosurgical meningitis presents unique management challenges due to potential resistance patterns.

Purpose of the Study:

  • To investigate the clinical features and antibiotic susceptibility of Acinetobacter meningitis in adult patients.
  • To compare Acinetobacter meningitis with other Gram-negative bacterial meningitis (GNBM) cases.
  • To identify challenges and guide initial management strategies for Acinetobacter meningitis.

Main Methods:

  • Retrospective analysis of 81 adult bacterial meningitis cases from 1999-2003.
  • Comparison of 13 Acinetobacter meningitis cases with 68 non-Acinetobacter GNBM cases.
  • Analysis of antibiotic susceptibility testing for Acinetobacter strains from cerebrospinal fluid.

Main Results:

  • Acinetobacter meningitis occurred in 13 cases, predominantly A. baumannii (12/13), with 11 post-neurosurgical infections.
  • High resistance rates were observed for ceftriaxone (8%), ciprofloxacin (46%), ceftazidime (46%), cefepime (54%), ampicillin-sulbactam (54%), with high susceptibility to imipenem (92%) and meropenem (92%).
  • A pan-drug resistant A. baumannii strain emerged in 2003. Acinetobacter meningitis was associated with hydrocephalus and ceftazidime resistance. Mortality was 30%, with significant neurological deficits in survivors.

Conclusions:

  • Acinetobacter meningitis, especially in post-neurosurgical settings, is challenging due to multidrug resistance and the emergence of pan-drug resistant strains.
  • Carbapenems, particularly meropenem, should be considered for initial empiric antibiotic therapy in adult post-neurosurgical meningitis.
  • Early recognition and appropriate antibiotic selection are crucial for improving outcomes in Acinetobacter meningitis.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...